Menu
Recruiting NCT07506798

Impact of Combined Intravenous-Inhalational vs Inhalational Anesthesia on QoR-15 Recovery Scores in Gynecologic Surgery

No phase Interventional Gynecologic Surgery Postoperative Recovery Anesthesia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Combined Intravenous-Inhalational Anesthesia, Inhalational Anesthesia Only.
Who it may be relevant to
Registry conditions: Gynecologic Surgery, Postoperative Recovery, Anesthesia. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Effects of Combined Intravenous-Inhalational Anesthesia Versus Inhalational Anesthesia on Postoperative Recovery in Gynecological Operations: A Comparison Based on QoR-15 Scores

Overview

This study aims to compare the effects of combined intravenous-inhalational anesthesia versus inhalational anesthesia alone on postoperative recovery in patients undergoing elective gynecologic surgery. A total of 100 patients, aged 18-65 years and classified as ASA I-III, scheduled for elective gynecologic procedures at Sakarya University Faculty of Medicine Training and Research Hospital, will be included. The sample size was calculated based on the primary outcome, the Quality of Recovery-15 (QoR-15) score. Patients will complete the QoR-15 questionnaire preoperatively, before knowing which anesthesia method will be applied. Postoperative QoR-15 scores will be collected on postoperative days 1 and 2, and intraoperative data will be obtained from anesthesia records. The study evaluates postoperative recovery using QoR-15 scores, covering physical comfort, emotional state, psychological support, pain, and ability to perform daily activities. Higher scores indicate better recovery, whereas lower scores indicate impaired postoperative recovery.

Interventions

  • Drug Combined Intravenous-Inhalational Anesthesia
    Patients will receive a combination of intravenous anesthetic agents and inhalational anesthetic gases during elective gynecologic surgery. The specific anesthetic drugs and doses will follow routine clinical practice. Postoperative recovery will be assessed using the Quality of Recovery-15 (QoR-15) questionnaire on postoperative days 1 and 2.
  • Drug Inhalational Anesthesia Only
    Patients will receive only inhalational anesthetic gases during elective gynecologic surgery, following routine clinical practice. Postoperative recovery will be assessed using the QoR-15 questionnaire on postoperative days 1 and 2.

Primary outcome measures

  • Postoperative recovery using QoR-15 [Time frame: Postoperative Day 1 and Postoperative Day 2]
Secondary outcome measures (3)
  • Postoperative pain score [Time frame: Postoperative hours 6, 12, and 24]
  • Postoperative nausea and vomiting (PONV) incidence [Time frame: Postoperative hours 0-24]
  • Length of stay in post-anesthesia care unit (PACU) [Time frame: Postoperative period (PACU stay), assessed up to 10 days]

Eligibility criteria

Inclusion criteria

  • Patients aged 18-65 years
  • Scheduled for elective gynecologic surgery at Sakarya University Faculty of Medicine Training and Research Hospital
  • Classified as ASA I-III
  • Able to understand and complete the QoR-15 questionnaire
  • Provided written informed consent

Exclusion criteria

  • Severe comorbidities (beyond ASA III)
  • Patients with advanced neurological disease or cognitive impairment
  • Known allergy to anesthetic drugs used in the study
  • Classified as ASA IV-V
  • Refusal to participate in the study
  • Emergency or urgent surgery

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Turkey (Türkiye) · 1 center
  • Sakarya University Training and Research Hospital — Sakarya

Identifiers

NCT: NCT07506798 · E.513181 (Application No: 473)

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗